Santanu Hati

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Characterization of quinoxaline derivatives for protection against iatrogenically induced hearing loss”.

Characterization of quinoxaline derivatives for protection against iatrogenically induced hearing loss

JCI Insight(2021)10.1172/jci.insight.141561

N/A

0DataRank · unranked

14 citations

Santanu Hati, Zhenhang Xu, William J. Hausman, Huizhan Liu, David Z. Z. He +2 more

In vivo Structure‐Activity Relationship of Dihydromethysticin in Reducing Nicotine‐Derived Nitrosamine Ketone (NNK)‐Induced Lung DNA Damage against Lung Carcinogenesis in A/J Mice

ChemMedChem(2022)10.1002/cmdc.202100727

N/A

0DataRank · unranked

8 citations

Qi Hu, Zhiguang Huo, Junxuan Lü, Chengguo Xing, Santanu Hati

In silico transcriptomics identifies FDA-approved drugs and biological pathways for protection against cisplatin-induced hearing loss

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.26.477836

N/A

0DataRank · unranked

2 citations

Marisa Zallocchi, Sarath Vijayakumar, Madeleine E. Urbanek, Kimberlee P. Giffen, Yuju Li +3 more